nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Methylprednisolone—ankylosing spondylitis	0.119	0.144	CbGbCtD
Toremifene—CYP1A1—Dexamethasone—ankylosing spondylitis	0.116	0.139	CbGbCtD
Toremifene—ABCB1—Betamethasone—ankylosing spondylitis	0.0776	0.0934	CbGbCtD
Toremifene—ABCB1—Prednisolone—ankylosing spondylitis	0.0766	0.0921	CbGbCtD
Toremifene—ABCB1—Prednisone—ankylosing spondylitis	0.0723	0.087	CbGbCtD
Toremifene—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0715	0.086	CbGbCtD
Toremifene—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0542	0.0652	CbGbCtD
Toremifene—CYP3A4—Betamethasone—ankylosing spondylitis	0.0465	0.0559	CbGbCtD
Toremifene—CYP3A4—Prednisolone—ankylosing spondylitis	0.0459	0.0552	CbGbCtD
Toremifene—ABCB1—Dexamethasone—ankylosing spondylitis	0.0451	0.0543	CbGbCtD
Toremifene—CYP3A4—Prednisone—ankylosing spondylitis	0.0433	0.0521	CbGbCtD
Toremifene—ABCB1—Methotrexate—ankylosing spondylitis	0.0363	0.0436	CbGbCtD
Toremifene—CYP3A4—Dexamethasone—ankylosing spondylitis	0.027	0.0325	CbGbCtD
Toremifene—Thromboembolic event—Methotrexate—ankylosing spondylitis	0.00351	0.0208	CcSEcCtD
Toremifene—Paresis—Methotrexate—ankylosing spondylitis	0.00259	0.0154	CcSEcCtD
Toremifene—Embolism—Prednisolone—ankylosing spondylitis	0.00243	0.0144	CcSEcCtD
Toremifene—Embolism—Triamcinolone—ankylosing spondylitis	0.00223	0.0132	CcSEcCtD
Toremifene—Embolism—Methylprednisolone—ankylosing spondylitis	0.00223	0.0132	CcSEcCtD
Toremifene—Glaucoma—Prednisolone—ankylosing spondylitis	0.00207	0.0123	CcSEcCtD
Toremifene—Hypercalcaemia—Methylprednisolone—ankylosing spondylitis	0.00206	0.0122	CcSEcCtD
Toremifene—Embolism—Dexamethasone—ankylosing spondylitis	0.00203	0.012	CcSEcCtD
Toremifene—Embolism—Betamethasone—ankylosing spondylitis	0.00203	0.012	CcSEcCtD
Toremifene—Glaucoma—Triamcinolone—ankylosing spondylitis	0.0019	0.0113	CcSEcCtD
Toremifene—Appetite absent—Methotrexate—ankylosing spondylitis	0.0019	0.0113	CcSEcCtD
Toremifene—Glaucoma—Methylprednisolone—ankylosing spondylitis	0.0019	0.0113	CcSEcCtD
Toremifene—Embolism—Prednisone—ankylosing spondylitis	0.00176	0.0105	CcSEcCtD
Toremifene—Glaucoma—Dexamethasone—ankylosing spondylitis	0.00173	0.0102	CcSEcCtD
Toremifene—Glaucoma—Betamethasone—ankylosing spondylitis	0.00173	0.0102	CcSEcCtD
Toremifene—Vaginal discharge—Methotrexate—ankylosing spondylitis	0.00156	0.00922	CcSEcCtD
Toremifene—Polyp—Methotrexate—ankylosing spondylitis	0.00156	0.00922	CcSEcCtD
Toremifene—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.00156	0.00922	CcSEcCtD
Toremifene—Cataract—Triamcinolone—ankylosing spondylitis	0.00151	0.00892	CcSEcCtD
Toremifene—Glaucoma—Prednisone—ankylosing spondylitis	0.0015	0.00891	CcSEcCtD
Toremifene—Embolism—Methotrexate—ankylosing spondylitis	0.00147	0.00874	CcSEcCtD
Toremifene—Cyst—Methotrexate—ankylosing spondylitis	0.00142	0.00839	CcSEcCtD
Toremifene—Liver disorder—Methotrexate—ankylosing spondylitis	0.00139	0.00823	CcSEcCtD
Toremifene—Cataract—Betamethasone—ankylosing spondylitis	0.00137	0.00809	CcSEcCtD
Toremifene—Cataract—Dexamethasone—ankylosing spondylitis	0.00137	0.00809	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.00131	0.00774	CcSEcCtD
Toremifene—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.0012	0.00712	CcSEcCtD
Toremifene—Dry eye—Dexamethasone—ankylosing spondylitis	0.0012	0.00712	CcSEcCtD
Toremifene—Dry eye—Betamethasone—ankylosing spondylitis	0.0012	0.00712	CcSEcCtD
Toremifene—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.0012	0.00711	CcSEcCtD
Toremifene—Cataract—Prednisone—ankylosing spondylitis	0.00119	0.00705	CcSEcCtD
Toremifene—Affect lability—Prednisolone—ankylosing spondylitis	0.00111	0.0066	CcSEcCtD
Toremifene—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.00109	0.00646	CcSEcCtD
Toremifene—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.00109	0.00646	CcSEcCtD
Toremifene—Mood swings—Prednisolone—ankylosing spondylitis	0.00107	0.00635	CcSEcCtD
Toremifene—Cardiac failure—Methylprednisolone—ankylosing spondylitis	0.00106	0.0063	CcSEcCtD
Toremifene—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.00105	0.00625	CcSEcCtD
Toremifene—Skin discolouration—Methotrexate—ankylosing spondylitis	0.00105	0.00621	CcSEcCtD
Toremifene—Affect lability—Triamcinolone—ankylosing spondylitis	0.00102	0.00607	CcSEcCtD
Toremifene—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00102	0.00605	CcSEcCtD
Toremifene—Mood swings—Triamcinolone—ankylosing spondylitis	0.000985	0.00584	CcSEcCtD
Toremifene—Mood swings—Methylprednisolone—ankylosing spondylitis	0.000983	0.00583	CcSEcCtD
Toremifene—Cardiac failure—Betamethasone—ankylosing spondylitis	0.000967	0.00573	CcSEcCtD
Toremifene—Cardiac failure—Dexamethasone—ankylosing spondylitis	0.000967	0.00573	CcSEcCtD
Toremifene—Lethargy—Dexamethasone—ankylosing spondylitis	0.000963	0.00571	CcSEcCtD
Toremifene—Lethargy—Betamethasone—ankylosing spondylitis	0.000963	0.00571	CcSEcCtD
Toremifene—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00095	0.00563	CcSEcCtD
Toremifene—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.000946	0.00561	CcSEcCtD
Toremifene—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000938	0.00556	CcSEcCtD
Toremifene—Affect lability—Betamethasone—ankylosing spondylitis	0.000929	0.00551	CcSEcCtD
Toremifene—Affect lability—Dexamethasone—ankylosing spondylitis	0.000929	0.00551	CcSEcCtD
Toremifene—Mood swings—Dexamethasone—ankylosing spondylitis	0.000894	0.0053	CcSEcCtD
Toremifene—Mood swings—Betamethasone—ankylosing spondylitis	0.000894	0.0053	CcSEcCtD
Toremifene—Weight increased—Prednisolone—ankylosing spondylitis	0.00089	0.00527	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000859	0.00509	CcSEcCtD
Toremifene—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000854	0.00506	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.000854	0.00506	CcSEcCtD
Toremifene—Cardiac failure—Prednisone—ankylosing spondylitis	0.000842	0.00499	CcSEcCtD
Toremifene—Lethargy—Prednisone—ankylosing spondylitis	0.000839	0.00497	CcSEcCtD
Toremifene—Weight increased—Triamcinolone—ankylosing spondylitis	0.000818	0.00485	CcSEcCtD
Toremifene—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000816	0.00484	CcSEcCtD
Toremifene—Affect lability—Prednisone—ankylosing spondylitis	0.000809	0.00479	CcSEcCtD
Toremifene—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.000794	0.0047	CcSEcCtD
Toremifene—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00079	0.00468	CcSEcCtD
Toremifene—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000788	0.00467	CcSEcCtD
Toremifene—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.000786	0.00466	CcSEcCtD
Toremifene—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000786	0.00466	CcSEcCtD
Toremifene—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000784	0.00465	CcSEcCtD
Toremifene—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.000784	0.00465	CcSEcCtD
Toremifene—Mood swings—Prednisone—ankylosing spondylitis	0.000779	0.00461	CcSEcCtD
Toremifene—Sweating—Methylprednisolone—ankylosing spondylitis	0.000767	0.00454	CcSEcCtD
Toremifene—Visual impairment—Prednisolone—ankylosing spondylitis	0.000754	0.00447	CcSEcCtD
Toremifene—Weight increased—Dexamethasone—ankylosing spondylitis	0.000742	0.0044	CcSEcCtD
Toremifene—Weight increased—Betamethasone—ankylosing spondylitis	0.000742	0.0044	CcSEcCtD
Toremifene—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000717	0.00425	CcSEcCtD
Toremifene—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000717	0.00425	CcSEcCtD
Toremifene—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000713	0.00423	CcSEcCtD
Toremifene—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000713	0.00423	CcSEcCtD
Toremifene—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.000713	0.00423	CcSEcCtD
Toremifene—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.000713	0.00423	CcSEcCtD
Toremifene—Lethargy—Methotrexate—ankylosing spondylitis	0.000701	0.00415	CcSEcCtD
Toremifene—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000699	0.00414	CcSEcCtD
Toremifene—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000692	0.0041	CcSEcCtD
Toremifene—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000671	0.00398	CcSEcCtD
Toremifene—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000651	0.00386	CcSEcCtD
Toremifene—Mood swings—Methotrexate—ankylosing spondylitis	0.000651	0.00386	CcSEcCtD
Toremifene—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000647	0.00383	CcSEcCtD
Toremifene—Weight increased—Prednisone—ankylosing spondylitis	0.000647	0.00383	CcSEcCtD
Toremifene—Ataxia—Methotrexate—ankylosing spondylitis	0.000646	0.00383	CcSEcCtD
Toremifene—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000643	0.00381	CcSEcCtD
Toremifene—Vision blurred—Prednisolone—ankylosing spondylitis	0.000642	0.0038	CcSEcCtD
Toremifene—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000641	0.0038	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000634	0.00376	CcSEcCtD
Toremifene—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000629	0.00373	CcSEcCtD
Toremifene—Visual impairment—Betamethasone—ankylosing spondylitis	0.000629	0.00373	CcSEcCtD
Toremifene—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000629	0.00373	CcSEcCtD
Toremifene—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000625	0.0037	CcSEcCtD
Toremifene—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000624	0.0037	CcSEcCtD
Toremifene—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000621	0.00368	CcSEcCtD
Toremifene—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000621	0.00368	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—ankylosing spondylitis	0.000621	0.00368	CcSEcCtD
Toremifene—Vertigo—Prednisolone—ankylosing spondylitis	0.000612	0.00363	CcSEcCtD
Toremifene—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00061	0.00362	CcSEcCtD
Toremifene—Eye disorder—Betamethasone—ankylosing spondylitis	0.00061	0.00362	CcSEcCtD
Toremifene—Back pain—Triamcinolone—ankylosing spondylitis	0.000606	0.00359	CcSEcCtD
Toremifene—Angiopathy—Betamethasone—ankylosing spondylitis	0.000592	0.00351	CcSEcCtD
Toremifene—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000592	0.00351	CcSEcCtD
Toremifene—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000583	0.00346	CcSEcCtD
Toremifene—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000583	0.00346	CcSEcCtD
Toremifene—Alopecia—Betamethasone—ankylosing spondylitis	0.000577	0.00342	CcSEcCtD
Toremifene—Alopecia—Dexamethasone—ankylosing spondylitis	0.000577	0.00342	CcSEcCtD
Toremifene—Vertigo—Triamcinolone—ankylosing spondylitis	0.000563	0.00334	CcSEcCtD
Toremifene—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000562	0.00333	CcSEcCtD
Toremifene—Oedema—Prednisolone—ankylosing spondylitis	0.000556	0.00329	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000537	0.00318	CcSEcCtD
Toremifene—Eye disorder—Prednisone—ankylosing spondylitis	0.000531	0.00315	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000528	0.00313	CcSEcCtD
Toremifene—Angiopathy—Prednisone—ankylosing spondylitis	0.000516	0.00306	CcSEcCtD
Toremifene—Oedema—Triamcinolone—ankylosing spondylitis	0.000511	0.00303	CcSEcCtD
Toremifene—Vertigo—Betamethasone—ankylosing spondylitis	0.000511	0.00303	CcSEcCtD
Toremifene—Vertigo—Dexamethasone—ankylosing spondylitis	0.000511	0.00303	CcSEcCtD
Toremifene—Arrhythmia—Prednisone—ankylosing spondylitis	0.000508	0.00301	CcSEcCtD
Toremifene—Sweating—Methotrexate—ankylosing spondylitis	0.000508	0.00301	CcSEcCtD
Toremifene—Insomnia—Prednisolone—ankylosing spondylitis	0.000503	0.00298	CcSEcCtD
Toremifene—Alopecia—Prednisone—ankylosing spondylitis	0.000502	0.00298	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000501	0.00297	CcSEcCtD
Toremifene—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.0005	0.00296	CcSEcCtD
Toremifene—Mental disorder—Prednisone—ankylosing spondylitis	0.000498	0.00295	CcSEcCtD
Toremifene—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000496	0.00294	CcSEcCtD
Toremifene—Malnutrition—Prednisone—ankylosing spondylitis	0.000495	0.00293	CcSEcCtD
Toremifene—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000494	0.00293	CcSEcCtD
Toremifene—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000493	0.00292	CcSEcCtD
Toremifene—Pain—Prednisolone—ankylosing spondylitis	0.000475	0.00282	CcSEcCtD
Toremifene—Vision blurred—Prednisone—ankylosing spondylitis	0.000467	0.00276	CcSEcCtD
Toremifene—Oedema—Dexamethasone—ankylosing spondylitis	0.000464	0.00275	CcSEcCtD
Toremifene—Oedema—Betamethasone—ankylosing spondylitis	0.000464	0.00275	CcSEcCtD
Toremifene—Insomnia—Triamcinolone—ankylosing spondylitis	0.000462	0.00274	CcSEcCtD
Toremifene—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000461	0.00273	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—ankylosing spondylitis	0.000458	0.00271	CcSEcCtD
Toremifene—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000456	0.0027	CcSEcCtD
Toremifene—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000455	0.0027	CcSEcCtD
Toremifene—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000455	0.0027	CcSEcCtD
Toremifene—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000454	0.00269	CcSEcCtD
Toremifene—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000454	0.00269	CcSEcCtD
Toremifene—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000448	0.00266	CcSEcCtD
Toremifene—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000448	0.00266	CcSEcCtD
Toremifene—Vertigo—Prednisone—ankylosing spondylitis	0.000445	0.00264	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—ankylosing spondylitis	0.000444	0.00263	CcSEcCtD
Toremifene—Anorexia—Betamethasone—ankylosing spondylitis	0.000442	0.00262	CcSEcCtD
Toremifene—Anorexia—Dexamethasone—ankylosing spondylitis	0.000442	0.00262	CcSEcCtD
Toremifene—Fatigue—Triamcinolone—ankylosing spondylitis	0.000441	0.00261	CcSEcCtD
Toremifene—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00044	0.00261	CcSEcCtD
Toremifene—Pain—Triamcinolone—ankylosing spondylitis	0.000437	0.00259	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—ankylosing spondylitis	0.000431	0.00256	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000428	0.00254	CcSEcCtD
Toremifene—Chills—Methotrexate—ankylosing spondylitis	0.000426	0.00253	CcSEcCtD
Toremifene—Alopecia—Methotrexate—ankylosing spondylitis	0.00042	0.00249	CcSEcCtD
Toremifene—Insomnia—Dexamethasone—ankylosing spondylitis	0.00042	0.00249	CcSEcCtD
Toremifene—Insomnia—Betamethasone—ankylosing spondylitis	0.00042	0.00249	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000419	0.00248	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—ankylosing spondylitis	0.000416	0.00247	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—ankylosing spondylitis	0.000414	0.00245	CcSEcCtD
Toremifene—Oedema—Prednisone—ankylosing spondylitis	0.000404	0.00239	CcSEcCtD
Toremifene—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000403	0.00239	CcSEcCtD
Toremifene—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000403	0.00239	CcSEcCtD
Toremifene—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000401	0.00237	CcSEcCtD
Toremifene—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000401	0.00237	CcSEcCtD
Toremifene—Back pain—Methotrexate—ankylosing spondylitis	0.0004	0.00237	CcSEcCtD
Toremifene—Fatigue—Dexamethasone—ankylosing spondylitis	0.0004	0.00237	CcSEcCtD
Toremifene—Fatigue—Betamethasone—ankylosing spondylitis	0.0004	0.00237	CcSEcCtD
Toremifene—Pain—Dexamethasone—ankylosing spondylitis	0.000397	0.00235	CcSEcCtD
Toremifene—Pain—Betamethasone—ankylosing spondylitis	0.000397	0.00235	CcSEcCtD
Toremifene—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000396	0.00235	CcSEcCtD
Toremifene—Skin disorder—Prednisone—ankylosing spondylitis	0.000392	0.00233	CcSEcCtD
Toremifene—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000391	0.00231	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—ankylosing spondylitis	0.00039	0.00231	CcSEcCtD
Toremifene—Anorexia—Prednisone—ankylosing spondylitis	0.000385	0.00228	CcSEcCtD
Toremifene—Vertigo—Methotrexate—ankylosing spondylitis	0.000372	0.0022	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—ankylosing spondylitis	0.00037	0.00219	CcSEcCtD
Toremifene—Dizziness—Prednisolone—ankylosing spondylitis	0.000368	0.00218	CcSEcCtD
Toremifene—Asthenia—Triamcinolone—ankylosing spondylitis	0.000367	0.00217	CcSEcCtD
Toremifene—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000366	0.00217	CcSEcCtD
Toremifene—Insomnia—Prednisone—ankylosing spondylitis	0.000365	0.00217	CcSEcCtD
Toremifene—Pruritus—Triamcinolone—ankylosing spondylitis	0.000362	0.00214	CcSEcCtD
Toremifene—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000361	0.00214	CcSEcCtD
Toremifene—Chest pain—Methotrexate—ankylosing spondylitis	0.000352	0.00209	CcSEcCtD
Toremifene—Decreased appetite—Prednisone—ankylosing spondylitis	0.000351	0.00208	CcSEcCtD
Toremifene—Rash—Prednisolone—ankylosing spondylitis	0.000351	0.00208	CcSEcCtD
Toremifene—Dermatitis—Prednisolone—ankylosing spondylitis	0.00035	0.00208	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00035	0.00207	CcSEcCtD
Toremifene—Fatigue—Prednisone—ankylosing spondylitis	0.000348	0.00206	CcSEcCtD
Toremifene—Headache—Prednisolone—ankylosing spondylitis	0.000348	0.00206	CcSEcCtD
Toremifene—Constipation—Prednisone—ankylosing spondylitis	0.000345	0.00205	CcSEcCtD
Toremifene—Dizziness—Triamcinolone—ankylosing spondylitis	0.000338	0.002	CcSEcCtD
Toremifene—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000337	0.002	CcSEcCtD
Toremifene—Asthenia—Dexamethasone—ankylosing spondylitis	0.000333	0.00197	CcSEcCtD
Toremifene—Asthenia—Betamethasone—ankylosing spondylitis	0.000333	0.00197	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000331	0.00196	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000331	0.00196	CcSEcCtD
Toremifene—Nausea—Prednisolone—ankylosing spondylitis	0.00033	0.00196	CcSEcCtD
Toremifene—Pruritus—Betamethasone—ankylosing spondylitis	0.000328	0.00194	CcSEcCtD
Toremifene—Pruritus—Dexamethasone—ankylosing spondylitis	0.000328	0.00194	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—ankylosing spondylitis	0.000328	0.00194	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000326	0.00193	CcSEcCtD
Toremifene—Vomiting—Triamcinolone—ankylosing spondylitis	0.000325	0.00193	CcSEcCtD
Toremifene—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000324	0.00192	CcSEcCtD
Toremifene—Rash—Triamcinolone—ankylosing spondylitis	0.000322	0.00191	CcSEcCtD
Toremifene—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000322	0.00191	CcSEcCtD
Toremifene—Anorexia—Methotrexate—ankylosing spondylitis	0.000322	0.00191	CcSEcCtD
Toremifene—Rash—Methylprednisolone—ankylosing spondylitis	0.000322	0.00191	CcSEcCtD
Toremifene—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000321	0.0019	CcSEcCtD
Toremifene—Headache—Triamcinolone—ankylosing spondylitis	0.00032	0.0019	CcSEcCtD
Toremifene—Headache—Methylprednisolone—ankylosing spondylitis	0.00032	0.00189	CcSEcCtD
Toremifene—Dizziness—Betamethasone—ankylosing spondylitis	0.000307	0.00182	CcSEcCtD
Toremifene—Dizziness—Dexamethasone—ankylosing spondylitis	0.000307	0.00182	CcSEcCtD
Toremifene—Insomnia—Methotrexate—ankylosing spondylitis	0.000305	0.00181	CcSEcCtD
Toremifene—Nausea—Triamcinolone—ankylosing spondylitis	0.000304	0.0018	CcSEcCtD
Toremifene—Nausea—Methylprednisolone—ankylosing spondylitis	0.000303	0.0018	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000301	0.00178	CcSEcCtD
Toremifene—Vomiting—Dexamethasone—ankylosing spondylitis	0.000295	0.00175	CcSEcCtD
Toremifene—Vomiting—Betamethasone—ankylosing spondylitis	0.000295	0.00175	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000294	0.00174	CcSEcCtD
Toremifene—Rash—Betamethasone—ankylosing spondylitis	0.000292	0.00173	CcSEcCtD
Toremifene—Rash—Dexamethasone—ankylosing spondylitis	0.000292	0.00173	CcSEcCtD
Toremifene—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000292	0.00173	CcSEcCtD
Toremifene—Dermatitis—Betamethasone—ankylosing spondylitis	0.000292	0.00173	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000291	0.00173	CcSEcCtD
Toremifene—Fatigue—Methotrexate—ankylosing spondylitis	0.000291	0.00172	CcSEcCtD
Toremifene—Headache—Betamethasone—ankylosing spondylitis	0.000291	0.00172	CcSEcCtD
Toremifene—Headache—Dexamethasone—ankylosing spondylitis	0.000291	0.00172	CcSEcCtD
Toremifene—Asthenia—Prednisone—ankylosing spondylitis	0.00029	0.00172	CcSEcCtD
Toremifene—Pain—Methotrexate—ankylosing spondylitis	0.000289	0.00171	CcSEcCtD
Toremifene—Pruritus—Prednisone—ankylosing spondylitis	0.000286	0.00169	CcSEcCtD
Toremifene—Nausea—Betamethasone—ankylosing spondylitis	0.000276	0.00163	CcSEcCtD
Toremifene—Nausea—Dexamethasone—ankylosing spondylitis	0.000276	0.00163	CcSEcCtD
Toremifene—Dizziness—Prednisone—ankylosing spondylitis	0.000267	0.00158	CcSEcCtD
Toremifene—Vomiting—Prednisone—ankylosing spondylitis	0.000257	0.00152	CcSEcCtD
Toremifene—Rash—Prednisone—ankylosing spondylitis	0.000255	0.00151	CcSEcCtD
Toremifene—Dermatitis—Prednisone—ankylosing spondylitis	0.000254	0.00151	CcSEcCtD
Toremifene—Headache—Prednisone—ankylosing spondylitis	0.000253	0.0015	CcSEcCtD
Toremifene—Asthenia—Methotrexate—ankylosing spondylitis	0.000242	0.00144	CcSEcCtD
Toremifene—Nausea—Prednisone—ankylosing spondylitis	0.00024	0.00142	CcSEcCtD
Toremifene—Pruritus—Methotrexate—ankylosing spondylitis	0.000239	0.00142	CcSEcCtD
Toremifene—Dizziness—Methotrexate—ankylosing spondylitis	0.000223	0.00132	CcSEcCtD
Toremifene—Vomiting—Methotrexate—ankylosing spondylitis	0.000215	0.00127	CcSEcCtD
Toremifene—Rash—Methotrexate—ankylosing spondylitis	0.000213	0.00126	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—ankylosing spondylitis	0.000213	0.00126	CcSEcCtD
Toremifene—Headache—Methotrexate—ankylosing spondylitis	0.000212	0.00125	CcSEcCtD
Toremifene—Nausea—Methotrexate—ankylosing spondylitis	0.000201	0.00119	CcSEcCtD
